We, the undersigned experts in regulatory science and medicine, are concerned about decisionmaking at the FDA related to the COVID-19 crisis. We are writing because there have been a number of headlines recently about the adequacy of the FDA’s evidentiary standards related to COVID-19 vaccines and its authority to make science-driven assessments about vaccine approval or authorization without…
Not all clinical trials are designed the same. Patients should choose well-designed patient-centric clinical trials for participation. #cancer #clinicaltrial…
Talk was given to participants of ColonCon in Kingston in February 2020.
This is a webinar delivered to patient advocates on June 25, 2020 organized by the National Breast Cancer Coalition. Link to the article discussed on…
Interview for ecancer based on my paper on cancer treatment in the last 6 months of life. Paper can be downloaded for free here: https://ecancer.org/en/journ…
This is a webinar delivered to patient advocates on June 25, 2020 organized by the National Breast Cancer Coalition. Link to the article discussed on…
This is a webinar delivered to patient advocates on June 25, 2020 organized by the National Breast Cancer Coalition. Link to the article discussed on…
Interview for ecancer based on my paper on cancer treatment in the last 6 months of life. Paper can be downloaded for free here: https://ecancer.org/en/journ…
Interview for ecancer based on my paper on cancer treatment in the last 6 months of life. Paper can be downloaded for free here: https://ecancer.org/en/journ…
My interview with the ecancer team based on my session at AORTIC 2019 #globaloncology
